Pharmacology of intracellular signalling pathways

British Journal of Pharmacology

Volumn 147, Issue SUPPL. 1, 2006, Pages

  Nahorski, Stefan R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Calcium ions; Cyclic AMP; Drug targets; Phosphoinositides; Protein kinases; Second messengers

Indexed keywords

CALCIUM ION; CYCLIC AMP; ENZYME INHIBITOR; G PROTEIN COUPLED RECEPTOR; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL PHOSPHATE; L 690330; L 690488; LITHIUM; MUSCARINIC RECEPTOR; PHOSPHATIDYLINOSITIDE; PROTEIN KINASE; UNCLASSIFIED DRUG;

BINDING AFFINITY; BIPOLAR DISORDER; DRUG TARGETING; EXTRACELLULAR CALCIUM; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION;

ANIMALS; CALCIUM SIGNALING; CYCLIC AMP; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LITHIUM COMPOUNDS; PHOSPHATIDYLINOSITOLS; PORTRAITS; RECEPTORS, G-PROTEIN-COUPLED; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 30444441415     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706468     Document Type: Review

References (47)

1. + in the treatment of bipolar disorder. Trends Neurosci., 18, 343-349.
2. BATTY, I., NAHORSKI, S.R. & IRVINE, R.F. (1985). Rapid formation of inositol(1,3,4,5)tetrakisphosphate following muscarinic receptor stimulation of rat cerebral cortical slices. Biochem. J., 232, 211-215.
3. BERRIDGE, M.J. (2004). Unlocking the secrets of cell signalling. Ann. Rev. Physiol., 67, 1-21.
4. BERRIDGE, M.J. & HESLOP, J.P. (1981). Separate 5-hydroxytryptamine receptors on the salivary-gland of the blowfly are linked to the generation of either cyclic adenosine-3′,5′-monophosphate or calcium signals. Br. J. Pharmacol., 73, 729-738.
5. BERRIDGE, M.J., DOWNES, C.P. & HANLEY, M.R. (1982). Lithium amplifies agonist dependent phosphatidylinositol responses in brain and salivary gland. Biochem. J., 206, 587-595.
6. BERRIDGE, M.J., DOWNES, C.P. & HANLEY, M.R. (1989). Neural and developmental actions of lithium: a unifying hypothesis. Cell, 59, 411-419.
7. BERRIDGE, M.J., LIPP, P. & BOOTMAN, M.D. (2000). The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell. Biol., 1, 11-21.
8. BROWN, B.L., ALBANO, J.D., EKINS, R.P. & SGHERZI, A.M. (1971). A simple and sensitive saturation assay method for the measurement of adenosine 3′, 5′ cyclic monophosphate. Biochem. J., 121, 561-562.
9. BUTCHER, R.W. & SUTHERLAND, E.W. (1962). Adenosine 3′,5′-phosphate in biological materials: I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine. J. Biol. Chem., 237, 1244-1250.
10. CARAFOLI, E. (2002). Calcium signalling: a tale for all seasons. Proc. Natl. Acad. Sci. U.S.A., 99, 1115-1122.
11. CHALLISS, R.A.J., BATTY, I.H. & NAHORSKI, S.R. (1988). Mass measurements of inositol(1,4,5)-trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization. Biochem. Biophys. Res. Commun., 157, 684-691.
12. CLAPPER, D.L., WALSETH, T.F., DARGIE, P.J. & LEE, H.C. (1987). Pyridine nucleotide metabolites stimulate calcium release from sea urchin egg microsomes. J. Biol. Chem., 262, 9561-9568.
13. COBBOLD, P.H. & RINK, T.J. (1987). Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem. J., 248, 313-328.
14. COHEN, P. (2002). Protein kinases - the major drug targets of the twenty-first century. Nat. Rev. Drug Disc., 1, 309-315.
15. COOPER, D.M.F., MONS, N. & KARPEN, J.W. (1995). Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature, 374, 421-424.
16. DANCEY, J. & SAUSVILLE, E.A. (2003). Issues and progress with protein kinase inhibitors for cancer treatment. Nat. Rev. Drug Disc., 2, 296-313.
17. EBASHI, S. & ENDO, M. (1968). Calcium ions and muscle contraction. Prog. Biophys. Mol. Biol., 18, 123-183.
18. FISHMAN, M.C. & PORTER, J.A. (2005). Pharmaceuticals: a new grammar for drug discovery. Nature, 437, 491-493.
19. GALIONE, A. & RUAS, M. (2005). NAADP receptors. Cell Calcium, 38, 273-280.
20. GILMAN, A.G. (1987). G proteins: transducers of receptor-generated signals. Ann. Rev. Biochem., 56, 615-649.
21. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
22. HALLCHER, L.M. & SHERMAN, W.R. (1980). The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem., 255, 10896-10901.
23. 3, and 40 years before. Nat. Rev. Mol. Cell. Biol., 4, 586-590.
24. IRVINE, R.F. & SCHELL, M.J. (2001). Back in the water: the return of the inositol phosphates. Nat. Rev. Mol. Cell. Biol., 2, 327-338.
25. IRVINE, R.F., LETCHER, A.J., LANDER, D.J. & DOWNES, C.P. (1984). Inositol trisphosphates in carbachol-stimulated rat parotid. Biochem. J., 232, 211-215.
26. JENKINSON, S., NAHORSKI, S.R. & CHALLISS, R.A.J. (1994). Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors. Mol. Pharmacol., 46, 1038-1048.
27. KAUMANN, A.J. & BIRNBAUMER, L. (1974). Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase: stereospecificity of ligands and apparent affinity constants for beta blockers. J. Biol. Chem., 249, 7874-7885.
28. KENAKIN, T. (1997). Pharmacological Analysis of Drug - Receptor Interactions, 3rd edn. Philadelphia and New York: Lippincott-Raven, pp 1-2.
29. KENAKIN, T. (2001). Inverse, protean and ligand-selective agonism: matters of receptor conformation. FASEB J., 15, 598-611.
30. MELNIKOVA, I. & GOLDEN, J. (2004). Targeting protein kinases. Nat. Rev. Drug Disc., 3, 993-994.
31. MICHELL, R.H. (1975). Inositol phospholipids and cell surface receptor function. Biochim. Biophys. Acta, 415, 81-147.
32. MUELLER, B.K., MACK, H. & TEUSCJ, N. (2005). Rho kinase, a promising drug target for neurological disorders. Nat. Rev. Drug Disc., 4, 387-398.
33. NAHORSKI, S.R. & POTTER, B.V.L. (1989). Molecular recognition of inositol polyphosphates by intracellular receptors and metabolic enzymes. Trends Pharmacol. Sci., 10, 139-144.
34. NAHORSKI, S.R., RAGAN, C.I. & CHALLISS, R.A.J. (1991). Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol. Sci., 12, 297-303.
35. NISHIZUKA, Y. (1984). The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 308, 693-698.
36. PFITZER, G. (2001). Invited review: regulation of myosin phosphorylation in smooth muscle. J. Appl. Physiol., 91, 497-503.
37. POZZAN, T., MONGILLO, M. & RUDOLF, R. (2003). The Theodore Bucher lecture: Investigating Signal transduction with genetically-encoded fluorescent probes. Eur. J. Biochem., 270, 2343-2352.
38. RIDGWAY, E.B. & ASHLEY, C.C. (1967). Calcium transients in single muscle fibers. Biochem. Biophys. Res. Commun., 29, 229-234.
39. RODBELL, M. (1980). The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature, 284, 17-22.
40. SAIARDI, A., BHANDARI, R., RESNICK, A.C., SOWMAN, A.M. & SNYDER, S.H. (2004). Phosphorylation of proteins by inositol pyrophosphates. Science, 306, 2101-2105.
41. SALOMON, Y. (1979). Adenylate cyclase assay. Adv. Cycl. Nucl. Res., 10, 35-55.
42. 2+ from a non-mitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate. Nature, 306, 67-69.
43. SUH, B.-C. & HILLE, B. (2005). Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate. Curr. Opin. Neurobiol., 15, 370-378.
44. SUTHERLAND, E.W. & RALL, T.W. (1958). Fractionisation and characterisation of a cyclic adenine ribonucletide formed by tissue peptides. J. Biol. Chem., 232, 1077-1091.
45. WALSH, D.A., PERKINS, J.P. & KREBS, E.G. (1968). An adenosine 3′,5′-monophosphate-dependent protein kinase from rabbit skeletal muscle. J. Biol. Chem., 243, 3763-3765.
46. WILCOX, R.A., PRIMROSE, W.U., NAHORSKI, S.R. & CHALLISS, R.A.J. (1998). New developments in the molecular pharmacology of the myo-inositol 1,4,5-trisphosphate receptor. Trends Pharmacol. Sci., 19, 467-475.
47. WONG, W. & SCOTT, J.D. (2004). AKAP signalling complexes: focal points in space and time. Nat. Rev. Cell Biol., 5, 959-969.